SK-09(Guangzhou Consun Pharma)

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameSK-09(Guangzhou Consun Pharma)
Drug Alias NameSK-09SK09
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNephrotic SyndromeNephrosisGlomerulosclerosis, Focal Segmental
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsNephrotic SyndromeNephrosisGlomerulosclerosis, Focal Segmental
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A